XML 27 R16.htm IDEA: XBRL DOCUMENT
v3.22.0.1

Stockholders' Equity | 3 Months Ended
--- | ---
Dec. 31, 2021
Equity [Abstract] |
Stockholders' Equity | Stockholders’ Equity The changes in stockholders’ equity for the prior year comparable period is as follows:
| Common Stock |  |  |  | Treasury Stock |  |  |  |  |  |
(dollars in thousands) | Shares |  | Amount |  | Additional Paid-in Capital |  | Shares |  | Amount |  | Accumulated Other Comprehensive Loss |  | Accumulated Deficit |  | Total
Balance at September 30, 2020 | 34,082,406 |  |  | $ | 34 |  |  | $ | 247,892 |  |  | $ | (547,508) |  |  | $ | (3,983) |  |  | $ | (9,782) |  |  | $ | (122,346) |  |  | $ | 111,815 |
Net income | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 4,514 |  |  | 4,514 |
Exercise of stock options, grants of restricted stock awards, and vesting of restricted stock units | 151,845 |  |  | — |  |  | 197 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 197 |
Taxes paid associated with net settlement of stock compensation awards | (7,703) |  |  | — |  |  | (57) |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (57) |
Forfeitures of restricted stock awards | (13,733) |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |
Common stock repurchased | — |  |  | — |  |  | — |  |  | (309,496) |  |  | (4,103) |  |  | — |  |  | — |  |  | (4,103) |
Common stock surrendered in the exercise of stock options | — |  |  | — |  |  | 169 |  |  | (9,384) |  |  | (169) |  |  | — |  |  | — |  |  | — |
Stock compensation expense | — |  |  | — |  |  | 1,801 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 1,801 |
Foreign currency translation | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 896 |  |  | — |  |  | 896 |
Balance at December 31, 2020 | 34,212,815 |  |  | $ | 34 |  |  | $ | 250,002 |  |  | $ | (866,388) |  |  | $ | (8,255) |  |  | $ | (8,886) |  |  | $ | (117,832) |  |  | $ | 115,063 |
Stock Compensation Incentive Plans The Company has several incentive plans under which stock options, restricted stock units (RSUs), restricted stock awards (RSAs), and cash-settled stock appreciation rights (SARs) have been issued, including the Third Amended and Restated 2006 Omnibus Long-Term Incentive Plan, as amended, and a plan and private placement issuances related to the Company’s acquisition of Machinio and Bid4Assets. As of December 31, 2021, the Company has reserved at total of 19,100,000 shares of its common stock for exercises of stock options, vesting of RSUs, and grants of RSAs under these plans. Vesting of RSUs and grants of RSAs count as 1.5x shares against the plan reserves. As of December 31, 2021, 994,605 shares of common stock remained available for use. Stock Compensation Expense The table below presents the components of share-based compensation expense (in thousands):
| Three Months Ended December 31, |  |
| 2021 |  | 2020 |  |  |  |
Equity-classified awards: |  |  |  |  |  |  |
Stock options | $ | 1,077 |  |  | $ | 884 |  |  |  |  |
RSUs & RSAs | 1,193 |  |  | 918 |  |  |  |  |
Total equity-classified awards | $ | 2,270 |  |  | $ | 1,802 |  |  |  |  |
Liability-classified awards: |  |  |  |  |  |  |
SARs | 10 |  |  | 427 |  |  |  |  |
Total stock compensation expense: | $ | 2,280 |  |  | $ | 2,229 |  |  |  |  |
The table below presents the components of share-based compensation expense by line item within our Condensed Consolidated Statement of Operations (in thousands):
| Three Months Ended December 31,
| 2021 |  | 2020
Stock Compensation Expense by Line Item |  |  |
Technology and operations | $ | 303 |  |  | $ | 367 |
Sales and marketing | 490 |  |  | 580 |
General and administrative | 1,487 |  |  | 1,282 |
Total stock compensation expense: | $ | 2,280 |  |  | $ | 2,229 |
Stock Options and RSUs & RSAs The following table presents stock option and RSUs & RSAs grant activity:
| Three Months Ended
| December 31, 2021
Stock Options granted: |
Options containing only service conditions: | 129,945 |
Weighted average exercise price | $ | 23.14 |
Weighted average grant date fair value | $ | 10.83 |
Options containing performance or market conditions: | 129,945 |
Weighted average exercise price | $ | 23.14 |
Weighted average grant date fair value | $ | 10.30 |
RSUs & RSAs granted: |
RSUs & RSAs containing only service conditions: 1 | 316,085 |
Weighted average grant date fair value | $ | 22.10 |
RSUs & RSAs containing performance or market conditions: 1 | 331,085 |
Weighted average grant date fair value | $ | 18.80 |
________________ 1 55,000 RSUs containing service conditions and 70,000 RSUs containing performance conditions were granted by private placement. The stock options and RSUs & RSAs containing only service conditions will vest over a four-year service period. The stock options and RSUs & RSAs containing performance conditions will vest upon the achievement of specified financial targets of the Company, a segment, or a division of a segment. The stock options and RSUs & RSAs containing market conditions will vest upon the achievement of specified increases in the Company’s share price. Vesting is measured the first day of each fiscal quarter over the four-year terms of the awards, starting with the first fiscal quarter after the first anniversary of the grant date, based upon the trailing 20-days average of the Company’s share price. The range of assumptions used to determine the fair value of stock options containing only service conditions using the Black-Scholes option-pricing model during the three months ended December 31, 2021 were as follows:
|  | Three Months Ended
|  | December 31, 2021
Dividend yield |  | — |
Expected volatility |  | 58.7% - 61.2%
Risk-free interest rate |  | 1.1% - 1.3%
Expected term |  | 4.5 - 5.0 years
The range of assumptions used to determine the fair value of stock options and RSUs & RSAs containing market conditions using Monte Carlo simulations during the three months ended December 31, 2021 were as follows:
|  | Three Months Ended
|  | December 31, 2021
Dividend yield |  | — |
Expected volatility |  | 57.2% - 62.9%
Risk-free interest rate |  | 1.1% - 1.5%
Expected holding period (% of remaining term) |  | 29.4% - 100.0%
SARs During the three months ended December 31, 2021, the Company did not issue any SARs, 750 SARs were exercised requiring the Company to make cash payments of less than $0.1 million, and 2,500 SARs were canceled. As of December 31, 2021, 38,795 SARs were outstanding. Share Repurchase Program We are authorized to repurchase issued and outstanding shares of our common stock under a share repurchase program approved by our Board of Directors. Share repurchases may be made through open market purchases, privately negotiated transactions or otherwise, at times and in such amounts as management deems appropriate. The timing and actual number of shares repurchased will depend on a variety of factors including price, corporate and regulatory requirements and other market conditions. The repurchase program may be discontinued or suspended at any time and will be funded using our available cash. The Company had no remaining share repurchase authorization as of September 30, 2021. On December 6, 2021, the Company's Board of Directors authorized a new stock repurchase plan (the "December 6 Stock Repurchase Plan") of up to $20 million of the Company's outstanding shares of common stock through December 31, 2023. During the three months ended December 31, 2021, the Company repurchased a total of 147,185 shares for $3.0 million under this program. As of December 31, 2021, the company may repurchase an additional $17.0 million of shares under this program. Other Share Repurchases Separate from the share repurchase program, our stock incentive plans allow for participants to exercise stock options by surrendering shares of common stock equivalent in value to the exercise price due. During the three months ended December 31, 2021 and December 31, 2020, participants surrendered 4,678 and 9,384 shares of common stock, respectively, in the exercise of stock options. Any shares surrendered to the Company in this manner are not available for future grant.

X
- References No definition available. + Details
Name: | us-gaap_EquityAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for shareholders' equity and share-based payment arrangement. Includes, but is not limited to, disclosure of policy and terms of share-based payment arrangement, deferred compensation arrangement, and employee stock purchase plan (ESPP). + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -URI http://asc.fasb.org/topic&trid=2208762 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -URI http://asc.fasb.org/topic&trid=2228938 + Details
Name: | us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration